share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/12 20:49
Moomoo AI 已提取核心信息
On March 10, 2024, James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a transaction involving the company's common stock. Kelly exercised options, acquiring 4,608 shares, and subsequently sold 2,226 shares at a price of $5.45 each. The total market value of the disposed shares amounted to $12,131.70. Following these transactions, Kelly directly holds 13,285 shares of Novavax common stock.
On March 10, 2024, James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a transaction involving the company's common stock. Kelly exercised options, acquiring 4,608 shares, and subsequently sold 2,226 shares at a price of $5.45 each. The total market value of the disposed shares amounted to $12,131.70. Following these transactions, Kelly directly holds 13,285 shares of Novavax common stock.
2024年3月10日，Novavax Inc执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利完成了一项涉及该公司普通股的交易。凯利行使了期权，收购了4,608股股票，随后以每股5.45美元的价格出售了2,226股股票。已处置股份的总市值为12,131.70美元。在这些交易之后，凯利直接持有13,285股Novavax普通股。
2024年3月10日，Novavax Inc执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利完成了一项涉及该公司普通股的交易。凯利行使了期权，收购了4,608股股票，随后以每股5.45美元的价格出售了2,226股股票。已处置股份的总市值为12,131.70美元。在这些交易之后，凯利直接持有13,285股Novavax普通股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息